CA
TDOC icon

Crewe Advisors’s Teladoc Health TDOC Stock Holding History

Crewe Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38
Closed -$349 – 791
2024
Q3 		$349 Hold
38
– – ﹤0.01% 680
2024
Q2 		$372 Sell
38
-202
-84% -$2.46K ﹤0.01% 922
2024
Q1 		$3.62K Buy
+240
New +$4.36K ﹤0.01% 788
2022
Q4 		– Sell
-103
Closed -$3K – 1257
2022
Q3 		$3K Hold
103
– – ﹤0.01% 991
2022
Q2 		$3K Buy
+103
New +$4.38K ﹤0.01% 926

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Crewe Advisors's TDOC Position: Q4 2024 in Review

Crewe Advisors sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 38 shares — an estimated $349 sold.

Crewe Advisors first reported a position in TDOC in Q2 2022 and held it in 5 quarters. The position peaked at $3.62K in Q1 2024. 380 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Crewe Advisors reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Crewe Advisors sold 38 Teladoc Health shares in Q4 2024, an estimated $349.
  • Crewe Advisors first reported a position in Teladoc Health in Q2 2022 and held it in 5 quarters.
  • Crewe Advisors's Teladoc Health position peaked at $3.62K in Q1 2024.
  • 380 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Crewe Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.